Dynavax Technologies | 当期純利益



Net Income 変化する 日付
AbbVie USD 938M 348M 2025-06
Adma Biologics USD 111.9M 75.99M 2024-12
Amgen USD 1.43B 298M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Dynavax Technologies USD 18.72M 114.82M 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
Glaxosmithkline GBP 414M 472M 2024-12
Merck USD 4.43B 652M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Novartis USD 4.02B 418M 2025-06
Pfizer USD 2.91B 58M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD 196.89M 644.4M 2025-06
TG Therapeutics USD 28.19M 23.13M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06


Dynavax Technologies 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.